Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 77948

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 05, 2017
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Ascend Laboratories LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC Montvale, NJ 07645, NDC 67877-199-10

D-1134-2017
Recall number
D-1134-2017
Initiated
May 05, 2017
Classification
Class III
Status
Terminated
Recalling firm
Ascend Laboratories LLC
Quantity
1212 bottles

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0
FOREIGN TABLETS

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.

Code information

Lot #: 6142626, Exp 09/19

Distribution pattern

Nationwide in the USA.